A detailed history of Bank Of New Hampshire transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Of New Hampshire holds 14,780 shares of NVO stock, worth $1.29 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
14,780
Previous 14,132 4.59%
Holding current value
$1.29 Million
Previous $2.02 Million 12.79%
% of portfolio
0.44%
Previous 0.53%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $77,157 - $94,232
648 Added 4.59%
14,780 $1.76 Million
Q2 2024

Jul 01, 2024

BUY
$122.71 - $146.91 $107,371 - $128,546
875 Added 6.6%
14,132 $2.02 Million
Q1 2024

Apr 10, 2024

BUY
$102.11 - $135.92 $1.26 Million - $1.68 Million
12,347 Added 1356.81%
13,257 $1.7 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $41,377 - $90,790
455 Added 100.0%
910 $82,000
Q1 2022

Apr 20, 2022

BUY
$93.1 - $112.54 $42,360 - $51,205
455 New
455 $51,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.